SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000902664-22-004380
Filing Date
2022-09-29
Accepted
2022-09-29 16:30:17
Documents
1

Document Format Files

Seq Description Document Type Size
1 PASSAGE BIO, INC. p22-2211sc13g.htm SC 13G 67236
  Complete submission text file 0000902664-22-004380.txt   68856
Mailing Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103
Business Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103 2678660312
Passage BIO, Inc. (Subject) CIK: 0001787297 (see all company filings)

IRS No.: 822729751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91451 | Film No.: 221280931
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 151 CALLE DE SAN FRANCISCO SUITE 200 PMB 1237 SAN JUAN PR 00901-1607
Business Address 151 CALLE DE SAN FRANCISCO SUITE 200 PMB 1237 SAN JUAN PR 00901-1607 703-963-7214
Lynx1 Capital Management LP (Filed by) CIK: 0001910456 (see all company filings)

IRS No.: 851134656 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G